Askenazi, David
Saeidi, Behtash
Koralkar, Rajesh
Ambalavanan, Namasivayam
Griffin, Russell L.
Funding for this research was provided by:
American Society of Nephrology (Norman Siegel Career Development Award)
National Institutes of Health (R01 DK13608-01)
University of Alabama at Birmingham (UL1TR00165)
National Institutes of Health (U01 HL122626; R01 HD067126; R01 HD066982; U10 HD34216)
Article History
Received: 25 June 2015
Revised: 16 October 2015
Accepted: 20 October 2015
First Online: 16 November 2015
Compliance with ethical standards
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board at the University of Alabama at Birmingham, as well all with the 1964 Declaration of Helsinki and its later amendments.
: Informed parental consent was obtained for all individual participants included in the study.
: Research reported in this publication was supported by the Norman Siegel Career Development Award from the American Society of Nephrology. Dr. Askenazi receives funding from the NIH (R01 DK13608-01) and the Pediatric and Infant Center for Acute Nephrology (PICAN), which is sponsored by Children’s of Alabama and the University of Alabama at Birmingham’s School of Medicine, Department of Pediatrics and Center for Clinical and Translational Science (CCTS) under award number UL1TR00165. Dr. Ambalavanan receives funding from NIH (grant # U01 HL122626; R01 HD067126; R01 HD066982; U10 HD34216). Dr. Griffin receives funding from UAB CCTS, and PICAN.
: Dr. Askenazi is a speaker for The Acute Kidney Injury Foundation.